Similarly, LIFR inhibition suppressed metastasis of pancreatic carcinoma and rhabdomyosarcoma, reduced stemness and growth of ovarian and breast cancers, and promoted apoptosis11,27. The gene discussed is LIFR; the disease is exocrine pancreatic carcinoma.